References
- Thompson JA, Lake JR. The impact of MELD allocation on simultaneous liver-kidney transplantation. Curr Gastroenterol Rep 2009;1:76–82.
- Ericzon BG, Suhr O, Broomé U, Holmgren G, Duraj F, Eleborg L, Wilkstrom L, Nordern G, Friman S, Groth CG. Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplant Proc 1995;27:1233.
- Lobato L, Beirão I, Costa PM, Fonseca I, Queirós J, Rocha G, Sarmento AM, Sousa A, Sequeiros J. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid 2004;66:27–37.
- Schmitt TM, Kumer SC, Al-Osaimi A, Shah N, Argo SK, Berg C, Pruett TL, North up PG. Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. Transpl Int 2009;22:876–883.
- Wilczek HE, Larsson M, Ericzon BG. Report of familial amyloidotic polyneuropathy world transplant registry www.fapwtr.org , 2009.
- Yamashita T, Ando Y, Ueda M, Nakamura M, Okamoto S, Zeledon ME, Hirahara T, Hirai T, Ueda A, Misumi Y, Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. Neurology 2008;70:123–128.
- De Carolis P, Galeotti M, Ficarra G, Masetti M, Grimaldi D, Cortelli P. Fatal cerebral haemorrhage after liver transplantation with transthyretin variant (gly53glu) amyloidosis. Neurol Sci 2006;27:352–354.
- Lehrke S, Steen H, Kristen AV, Merten C, Lossnitzer D, Dengler TJ, Katus HA, Giannitsis E. Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis. Amyloid 2009;16:187–195.